| Literature DB >> 28705247 |
David J Clancy1, Michel Slama1, Stephen Huang1, Timothy Scully1, Anthony S McLean1, Sam R Orde2.
Abstract
BACKGROUND: Left ventricular diastolic dysfunction is associated with mortality outcomes in severe sepsis and septic shock. There are ongoing issues with diagnosing diastolic dysfunction in this cohort, partly owing to the poor applicability of traditional parameters in the hyperdynamic circulation. In this feasibility study, we sought to assess the utility of a novel parameter (septal e'/s') to identify diastolic dysfunction in patients with severe sepsis and septic shock who had normal systolic function against the 2016 American Society Echocardiography and European Association of Cardiovascular Imaging (ASE/EACI) guidelines on diastolic dysfunction.Entities:
Keywords: Diastolic function; Myocardial relaxation; Sepsis
Mesh:
Year: 2017 PMID: 28705247 PMCID: PMC5512826 DOI: 10.1186/s13054-017-1727-9
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Fig. 1Flowchart of participants in study. e′/s′ Ratio of early diastolic to systolic myocardial tissue velocity
Fig. 2Septal e′ versus s′ in all patients on day 1. The dashed blue line represents the linear relationship between septal e′ and s′ for patients with normal systolic and diastolic function (e′ = 0.96 s′ + 0.004, r 2 = 0.0762, p < 0.001). The red dotted line represents the relationship between septal e′ and s′ for those with normal systolic function but abnormal diastolic function (e′ = 0.346 s′ + 0.0296, r 2 = 0.34, p = 0.007). Those with normal systolic function but indeterminate diastolic function did not have a significant linear relationship (e′ = 0.0782 s′ + 0.049, r 2 = 0.02, p = 0.628), but all patients had a septal e′/s′ ratio that was lower than the line of best fit for the normal systolic and normal diastolic function group. Those with abnormal systolic function had a much weaker linear relationship (e′ = 0.34 s′ + 0.03, r 2 = 0.24, p = 0.04). e′/s′ Ratio of early diastolic to systolic myocardial tissue velocity
Baseline demographics of all patients, those with septal e′/s′ <1 and those with septal e′/s′ >1 on days 1 and 3
| Day 1 | Day 3 | |||||
|---|---|---|---|---|---|---|
| Variable | All patients, day 1 ( | Septal e′/s′ <1, | Septal e′/s′ >1, | All patients day 3 ( | Septal e′/s′ <1, | Septal e′/s′ >1, |
| Demographics | ||||||
| Age, years | 63 ± 12 | 65 ± 10 | 56 ± 15 | 62 ± 11 | 64 ± 12a | 56 ± 9 |
| Male sex | 19 (43%) | 13 (39%) | 6 (55%) | 17 (46%) | 13 (48%) | 4 (40%) |
| Mortality (ICU) | 9 (20%) | 7 (21%) | 2 (18%) | 5 (14%) | 5 (19%) | 0 |
| Mortality (hospital) | 12 (28%) | 10 (30%) | 2 (18%) | 9 (24%) | 9 (33%) | 0 |
| Past medical history | ||||||
| IHD | 10 (23%) | 9 (27%) | 1 (9%) | 7 (19%) | 7 (26%) | 0 |
| Diabetes mellitus | 12 (28%) | 11 (33%) | 1 (9%) | 10 (27%) | 7 (26%) | 3 (30%) |
| Hypertension | 25 (57%) | 21 (64%) | 4 (36%) | 22 (59%) | 18 (67%) | 4 (40%) |
| Known diastolic dysfunction | 5 (11%) | 4 (12%) | 1 (9%) | 3 (8%) | 3 (11%) | 0 |
| Chronic kidney injury | 8 (18%) | 8 (24%) | 0 | 8 (22%) | 7 (4%) | 1 (10%) |
| Clinical data | ||||||
| Ventilator days | 5 (1–9) | 5 (2–9) | 3 (0–6) | 5 (1–8) | 5 (1–9) | 4 (2–8) |
| HR (on day of study) | 96 ± 19 | 96 ± 17 | 96 ± 25 | 89 ± 18 | 89 ± 19 | 90 ± 15 |
| Arrhythmia | 8 (18%) | 5 (15%) | 3 (27%) | 7 (19%) | 7 (26%) | 0 |
| SOFA | 9 (7–12) | 9 (6–13) | 10 (7–12) | 6 (3–9) | 6 (3–11) | 6.5 (3–8) |
| PEEP, cmH2O | 8 (5–10) | 10 (7–14) | 8 (5–10) | 7 (5–10) | 5 (7–10) | 6 (5–11) |
| Fluid balance, ml | 1042 (349–2391) | 1174 (363–2425) | 544 (332–2120) | 2588 ± 3958 | 3012 ± 4203 | 3106 ± 1443 |
| Noradrenaline, total mg | 155 (45–334) | 200a (70–362) | 49 (4–158) | 441 (46–841) | 364 (38– 851) | 467 (94–829) |
Abbreviations: e′/s′ Ratio of early diastolic to systolic myocardial tissue velocity, HR Heart rate, ICU Intensive care unit, IHD Ischaemic heart disease, PEEP Peak end-expiratory pressure, SOFA Sepsis-related Organ Failure Assessment
a p < 0.05
Fig. 3Patients with normal systolic function on day 1 and day 3 with presence of diastolic dysfunction versus septal ratio of early diastolic to systolic myocardial tissue velocity (e′/s′)
Echocardiography parameters of patients with septal e′/s′ <1 and patients with septal e′/s′ >1 on days 1 and 3
| Day 1 | Day 3 | |||
|---|---|---|---|---|
| Echocardiography parameter | Septal e′/s′ <1 ( | Septal e′/s′ >1 ( | Septal e′/s′ < 1 ( | Septal e′/s′ >1 ( |
| Mean septal e′/s′ | 0.71 ± 0.14a | 1.05 ± 0.11 | 0.70 ± 0.15a | 1.16 ± 0.20 |
| Septal hypertrophy, | 15a | 1 | 12 | 1 |
| E/e′ >14, | 10 | 1 | 12a | 0 |
| Mean E/e′ | 13 ± 5 | 10.6 ± 3.15 | 14.5 ± 8a | 8.8 ± 2.6 |
| Septal e′ <7 cm/s, | 25a | 3 | 19a | 1 |
| Mean septal e′, cm/s | 5.7 ± 1a | 8 ± 3 | 6 ± 2a | 9 ± 2 |
| Lateral e′ <10 cm/second, | 28 | 8 | 18 | 4 |
| Average lateral e′, cm/second | 8 ± 2 | 8.6 ± 2 | 8 ± 3a | 10 ± 2 |
| Increased left atrial volume, | 21 | 5 | 22 | 4 |
| Mean left atrial volume, ml | 66 ± 27 | 59 ± 21 | 84 ± 33a | 55 ± 22 |
| TR velocity >2.8 m/second, | 9 | 2 | 10 | 1 |
| TR velocity, m/second, average | 2.6 ± 0.7 | 2.4 ± 0.6 | 2.8 ± 0.6a | 2.2 ± 0.5 |
| Mitral s′ average, cm/second | 8 ± 2 | 7.5 ± 2 | 8 ± 2 | 7.6 ± 1 |
| Cardiac output, L/minute | 6.2 ± 2.2 | 5.4 ± 1.5 | 6.7 ± 2 | 6 ± 1.5 |
| SV, ml | 65 ± 24 | 61 ± 17 | 72 ± 21 | 66 ± 10 |
| VTI, cm | 20 ± 6.5 | 17 ± 4.4 | 21 ± 5 | 19 ± 2.3 |
| Diastolic dysfunction | 18a | 2 | 19a | 1 |
| Indeterminate diastolic dysfunction | 13a | 0 | 6a | 1 |
Abbreviations: E/e′ Ratio of early diastolic mitral inflow velocity to early diastolic myocardial tissue velocity, e′/s′ Ratio of early diastolic to systolic myocardial tissue velocity, SV Stroke volume, TR Tricuspid regurgitation, VTI Velocity time integral
a p < 0.05
Fig. 4ROC curves for day 1 and day 3 septal ratio of early diastolic to systolic myocardial tissue velocity (e′/s′) versus diastolic dysfunction in patients with normal systolic function